Bluedrop - Remote Patient Monitoring Device

25% Develop An Ulcer
1 in 4 people with diabetes will develop a foot ulcer at some point in their life. The risk increases with the presence of complications such as peripheral neuropathy.

86,000 Amputations Per Year In USA
An average of 86,000 amputations are required each year in the USA as a result of diabetic foot ulcers. The majority of these are preventable.

$17 Billion Per Year
In the US, the annual cost of treating diabetic foot ulcers is $17 billion. The average cost per ulcer is $17,000 with amputations often costing a multiple of that.(4)

40% Re-Ulceration Per Year
After an ulcer heals approximately 40% of patients will develop a second ulcer within 12 months.

Our patented technology is the world’s first home use device to enable a thermal and visual assessment from a single daily scan.

If a hot spot is detected, visual assessment by a clinician is required

Time is critical. Delays lead to ulcers, delays lead to amputations

Our HD images allow remote visual assessment and remote care by a clinician, as soon as an issue arises

Used in the home, the patient simply stands on the device for 30 seconds and goes about the rest of their day.

A scan of the feet is taken which includes detailed thermal and HD photographic information.

The condition of the soles of the feet will be remotely monitored for the thermal and visual signs of inflammation and skin damage.

• Enables remote visual and thermal assessment and remote intervention using HD visual images and thermal data
• Monitor for signs of inflammation and skin damage which may signal the onset of a foot ulcer
• Population management tools. Longitudinal assessment of thermal, visual, weight and compliance data
• Stay connected to your patients post healing and between scheduled clinic visits
• We provide full tech support leaving you to focus on better care
• May form the backbone of your CMS compliant Remote Patient Monitoring (RPM) programme

Every year, in the USA alone, there are approximately 100,000 amputations as a result of diabetic foot ulcers a figure which is similar across the developed world. In England in 2015 there was a record 200 amputations per day and 7,370 for the year.

Many people with diabetes suffer from nerve damage in their lower extremities known as peripheral neuropathy resulting in reduced or eliminated sensation in their legs and feet. This reduction in sensation means that cuts and sores go un-noticed by the patient and can develop into ulcers. These ulcers are often not identified until days or weeks after they first occur and healing is often extremely slow, taking months or even years to heal. In many cases the wounds become infected which can lead to amputation in order to stop the infection spreading.

Up to 25% of all people with diabetes will develop a foot ulcer at some point in their life but for the high risk group the annual incidence of diabetic foot ulcers is as high as 40%. High risk patients are those that suffer from peripheral neuropathy and peripheral vascular disease or who have a history of ulceration.

The total cost of treating diabetic foot ulcers in the USA has been estimated as being $17 billion. In addition to the huge financial cost, the human cost of a diabetic amputation is almost unquantifiable. Aside from the clear impact losing a limb would have on mobility and independence, it is also linked with a severely reduced quality of life and higher rates of depression. More worrying is the mortality rate of a patient post amputation. The relative 5-year mortality rate is 68%, and is worse than all forms of cancer except lung. In addition to this the recurrence rate of amputations is extremely high with 9-20% receiving a second amputation after year 1 and 28-51% after year 55.